The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Astley-sparke Philip since 2018.
This trader's CIK number is 1376491.
At the time of last reporting, Astley-sparke Philip was the Officer of Replimune Group, Inc.. (stock ticker symbol REPL).
Also see all insider trading activities at Replimune Group, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | QURE | 0 | $0 | 504 | $18,950 | 0 | $0 |
| 2020 | QURE | 0 | $0 | 807 | $47,798 | 0 | $0 |
| 2019 | QURE | 0 | $0 | 19,670 | $1,162,378 | 0 | $0 |
| 2018 | QURE | 0 | $0 | 11,540 | $273,136 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | REPL | 0 | $0 | 32,279 | $260,168 | 0 | $0 |
| 2023 | REPL | 0 | $0 | 17,902 | $323,131 | 0 | $0 |
| 2022 | REPL | 0 | $0 | 9,632 | $140,530 | 0 | $0 |
| 2021 | REPL | 0 | $0 | 50,000 | $2,183,322 | 0 | $0 |
| 2020 | REPL | 0 | $0 | 50,000 | $2,174,025 | 0 | $0 |
| 2019 | REPL | 0 | $0 | 87,000 | $1,480,769 | 0 | $0 |
2. Replimune Group, Inc. (REPL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-03-02 | QURE | Sale | 504 | 37.60 | 18,950 |
| 2020-01-30 | QURE | Sale | 807 | 59.23 | 47,798 |
| 2019-08-01 | QURE | Sale | 6,460 | 59.81 | 386,391 |
| 2019-06-03 | QURE | Sale | 6,000 | 63.17 | 379,050 |
| 2019-04-01 | QURE | Sale | 6,000 | 59.84 | 359,040 |
| 2019-01-28 | QURE | Sale | 1,210 | 31.32 | 37,897 |
| 2018-12-03 | QURE | Sale | 5,000 | 30.39 | 151,950 |
| 2018-01-29 | QURE | Sale | 6,540 | 18.53 | 121,186 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-05-20 | REPL | Sale | 32,279 | 8.06 | 260,168 |
| 2023-05-16 | REPL | Sale | 17,902 | 18.05 | 323,131 |
| 2022-05-16 | REPL | Sale | 9,632 | 14.59 | 140,530 |
| 2021-01-15 | REPL | Sale | 16,568 | 43.89 | 727,219 |
| 2021-01-14 | REPL | Sale | 25,000 | 43.82 | 1,095,425 |
| 2021-01-19 | REPL | Sale | 8,432 | 42.77 | 360,678 |
| 2020-12-09 | REPL | Sale | 25,000 | 43.93 | 1,098,200 |
| 2020-12-10 | REPL | Sale | 25,000 | 43.03 | 1,075,825 |
| 2019-11-06 | REPL | Sale | 29,000 | 17.01 | 493,290 |
| 2019-11-04 | REPL | Sale | 29,000 | 17.03 | 493,754 |
| 2019-10-31 | REPL | Sale | 14,500 | 17.00 | 246,500 |
| 2019-09-23 | REPL | Sale | 14,500 | 17.05 | 247,225 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Astley-sparke Philip (Officer of Replimune Group, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.